Skip to main content
Fig. 3 | BMC Anesthesiology

Fig. 3

From: Moxifloxacin monotherapy versus combination therapy in patients with severe community-acquired pneumonia evoked ARDS

Fig. 3

Thirty-day survival in patients with severe CAP evoked acute respiratory distress syndrome (ARDS) stratified for the antibiotic treatment regime after ICU admission. Kaplan-Meier estimates were used to calculate probabilities of 30-day survival. Thirty-day survival was not significantly different (p = 0.889) between moxifloxacin monotherapy (Moxi-Mono), moxifloxacin combination therapy (Moxi-Combi), and other regimens (Other)

Back to article page

BMC Anesthesiology

ISSN: 1471-2253

Contact us